Altria's Bet on Capex: Strength or Desperation? Altria's decision to raise its capital expenditures by 100% has sent shockwaves through the consumer staples sector.
The tobacco company's move outpaces its peers, leaving investors wondering whether it's a sign of strength or desperation.
On one hand, Altria's Q2 results show that the company can still afford to invest, with revenue rising 0. 1% year over year and adjusted EPS increasing 3%. Its dividend remains a major draw for investors, yielding 6.